TITLE
Masitinib-gemcitabin effect on gemcitabine-refractory Mia Paca-2 pancreatic tumor cell line

SUMMARY
Analysis of Mia Paca2 cells after treatment with masitinib combined with standard gemcitabine chemotherapy. Masitinib is a tyrosine kinase inhibitor of c-Kit, PDGFRα and β. Results provide insight into the therapeutic potential of masitinib in vitro on human pancreatic tumor cell lines.

ORGANISM
Homo sapiens

